Skip header and navigation

6 records – page 1 of 1.

Cancer and the Risk of Blood Clots

https://libcat.nshealth.ca/en/permalink/chpams37420
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1675
Available Online
View Pamphlet
Cancer patients may be more at risk of developing blood clots, also called Cancer Associated Thrombosis or CAT. This pamphlet describes what blood clots are, those at highest risk, and what conditions may come from CAT. Terms used in the guide are explained.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Blood Coagulation Disorders
Neoplasms - complications
Subjects (LCSH)
Blood coagulation disorders
Cancer--Complications
Specialty
Hematology
Abstract
Cancer patients may be more at risk of developing blood clots, also called Cancer Associated Thrombosis or CAT. This pamphlet describes what blood clots are, those at highest risk, and what conditions may come from CAT. Terms used in the guide are explained.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1675
Less detail

Deep vein thrombosis (DVT) and pulmonary embolism (PE)

https://libcat.nshealth.ca/en/permalink/chpams36560
Nova Scotia Health Authority. QEII. Hematology Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1141
Available Online
View Pamphlet
This pamphlet will help you learn about deep vein thrombosis (DVT) and pulmonary embolism (PE). You must be able to recognize certain symptoms so you can get medical care right away. This pamphlet explains what DVTs and PEs are and whether they are dangerous, the symptoms and treatment for each, why blood clots form, and how to lower your risk of another DVT or PE. Information about what to do if you think you are having another DVT or PE is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Hematology Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Venous Thrombosis - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Thrombophlebitis
Pulmonary embolism--Prevention
Specialty
Cardiovascular System
Abstract
This pamphlet will help you learn about deep vein thrombosis (DVT) and pulmonary embolism (PE). You must be able to recognize certain symptoms so you can get medical care right away. This pamphlet explains what DVTs and PEs are and whether they are dangerous, the symptoms and treatment for each, why blood clots form, and how to lower your risk of another DVT or PE. Information about what to do if you think you are having another DVT or PE is included.
Responsibility
Prepared by: Hematology Services. QEII
Pamphlet Number
1141
Less detail

Preventing blood clots while in the hospital

https://libcat.nshealth.ca/en/permalink/chpams35476
Nova Scotia Health Authority. Performance Excellence. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1542
Available Online
View Pamphlet
This pamphlet will explain what blood clots are and why they happen. It also explains what your health care team will do to help prevent a blood clot from happening to you, as well as how you can tell if you might have a blood clot. Finally, it will go over what you can do to help prevent yourself from getting a blood clot. The French version of this pamphlet 1545, "Prévenir la formation de caillots de sang lors d’une hospitalisation", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Performance Excellence
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Venous Thrombosis - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Thrombophlebitis
Abstract
This pamphlet will explain what blood clots are and why they happen. It also explains what your health care team will do to help prevent a blood clot from happening to you, as well as how you can tell if you might have a blood clot. Finally, it will go over what you can do to help prevent yourself from getting a blood clot. The French version of this pamphlet 1545, "Prévenir la formation de caillots de sang lors d’une hospitalisation", is also available.
Responsibility
Prepared by: Performance Excellence
Pamphlet Number
1542
Less detail

Prévenir la formation de caillots de sang lors d’une hospitalisation

https://libcat.nshealth.ca/en/permalink/chpams35481
Nova Scotia Health Authority. Performance Excellence. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1545
Available Online
View Pamphlet
La présente publication explique ce qu’est un caillot de sang et ce qui en provoque la formation, ce que votre équipe de soins de santé fera pour vous protéger contre la formation d’un caillot de sang, les symptômes de la présence potentielle d’un caillot de sang et ce que vous pouvez faire pour prévenir la formation d’un caillot de sang. ; This is a French translation of the English pamphlet 1542, "Preventing Blood Clots While in the Hospital". This pamphlet will explain what blood clots are a…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Performance Excellence
Alternate Title
Preventing blood clots while in the hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Venous Thrombosis - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Thrombophlebitis
Abstract
La présente publication explique ce qu’est un caillot de sang et ce qui en provoque la formation, ce que votre équipe de soins de santé fera pour vous protéger contre la formation d’un caillot de sang, les symptômes de la présence potentielle d’un caillot de sang et ce que vous pouvez faire pour prévenir la formation d’un caillot de sang.
This is a French translation of the English pamphlet 1542, "Preventing Blood Clots While in the Hospital". This pamphlet will explain what blood clots are and why they happen. It also explains what your health care team will do to help prevent a blood clot from happening to you, as well as how you can tell if you might have a blood clot. Finally, it will go over what you can do to help prevent yourself from getting a blood clot.
Responsibility
Prepared by: Performance Excellence
Pamphlet Number
1545
Less detail

Warfarine sodique

https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2063
Available Online
View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Warfarin sodium
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
2063
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Hematology Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0373
Available Online
View Pamphlet
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the An…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Services
Nova Scotia Health Authority. QEII. Hematology Services
Alternate Title
Coumadin
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Specialty
Medications
Abstract
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the Anticoagulation Clinic and the Thrombosis Anticoagulation Program is provided. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
Notes
Previous title: Warfarin sodium, an oral anticoagulant
Responsibility
Prepared by: Pharmacy Services and Hematology Services, QEII
Pamphlet Number
0373
Less detail

6 records – page 1 of 1.